Scientists are hoping that a single drug can treat two devastating brain diseases: Parkinson’s and Alzheimer’s. The drug is nilotinib, which is approved to treat a form of leukemia.

Read the full article at npr.org

http://www.npr.org/sections/health-shots/2017/03/15/520170960/cancer-drug-that-might-slow-parkinson-s-alzheimer-s-headed-for-bigger-tests

Share This